Home Page  / Our Company  / R&D

R&D

W

hen the basic investigation phase and marketing activities are taken into account, development of a new drug takes years. Our Company is aware of the fact that progress is required for R&D procedures, and has designed its financial and organizational structure and operation on the basis of this requirement, and works hard to ensure sustainability. We are fully aware that, in order to attain our targets, we need not only to widen our viewpoint with various partnerships but also to possess a substructure making pharmaceutical development possible.


As the outcome of this awareness, the manufacturing site for which the foundations will soon be laid and the clinical studies at the design phase are important steps taken by us to develop and manufacture innovative drugs capable of fulfilling medical needs that are currently unmet on a worldwide basis.

Information in our website will not replace information provided by a physician or pharmacist. Hasbiotech does not assume any legal responsibility for cases arising out of the abuse or misuse of information and references contained hereunder. The information offered in this website is intended for target users and may not be distributed to third parties or copied by others. Unauthorized use of registered marks and texts in this website is not allowed. By using this website, all users are deemed to have accepted this legal warning.

You may access the remaining part of the website only after confirming that you are a healthcare professional (physician, pharmacist, dentist etc.).

Click the “I agree” button if you are confirming that you are a healthcare professional (physician, pharmacist, dentist etc.). Otherwise, click the “I do not agree” button.
I agree I do not agree